These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22936421)

  • 1. Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?
    Wagenmakers MA; Netea-Maier RT; Prins JB; Dekkers T; den Heijer M; Hermus AR
    Eur J Endocrinol; 2012 Nov; 167(5):687-95. PubMed ID: 22936421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing's syndrome.
    Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
    Eur J Endocrinol; 2011 Oct; 165(4):527-35. PubMed ID: 21798958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affective alterations in patients with Cushing's syndrome in remission are associated with decreased BDNF and cortisone levels.
    Valassi E; Crespo I; Keevil BG; Aulinas A; Urgell E; Santos A; Trainer PJ; Webb SM
    Eur J Endocrinol; 2017 Feb; 176(2):221-231. PubMed ID: 27932530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drawings reflect a new dimension of the psychological impact of long-term remission of Cushing's syndrome.
    Tiemensma J; Daskalakis NP; van der Veen EM; Ramondt S; Richardson SK; Broadbent E; Romijn JA; Pereira AM; Biermasz NR; Kaptein AA
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3123-31. PubMed ID: 22723334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personality characteristics and quality of life in patients treated for Cushing's syndrome.
    Sonino N; Bonnini S; Fallo F; Boscaro M; Fava GA
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):314-8. PubMed ID: 16487442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study.
    Andela CD; van der Werff SJ; Pannekoek JN; van den Berg SM; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Romijn JA; Tiemensma J; Biermasz NR; van der Wee NJ; Pereira AM
    Eur J Endocrinol; 2013 Dec; 169(6):811-9. PubMed ID: 24031092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission.
    Lindsay JR; Nansel T; Baid S; Gumowski J; Nieman LK
    J Clin Endocrinol Metab; 2006 Feb; 91(2):447-53. PubMed ID: 16278266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire.
    Webb SM; Badia X; Barahona MJ; Colao A; Strasburger CJ; Tabarin A; van Aken MO; Pivonello R; Stalla G; Lamberts SW; Glusman JE
    Eur J Endocrinol; 2008 May; 158(5):623-30. PubMed ID: 18426820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN.
    Valassi E; Feelders R; Maiter D; Chanson P; Yaneva M; Reincke M; Krsek M; Tóth M; Webb SM; Santos A; Paiva I; Komerdus I; Droste M; Tabarin A; Strasburger CJ; Franz H; Trainer PJ; Newell-Price J; Wass JA; Papakokkinou E; Ragnarsson O;
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):787-798. PubMed ID: 29574994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent centripetal fat distribution and metabolic abnormalities in patients in long-term remission of Cushing's syndrome.
    Wagenmakers M; Roerink S; Gil L; Plantinga T; Smit J; Netea-Maier R; Hermus A
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):180-7. PubMed ID: 25323660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of functional remission in Cushing's syndrome.
    Vermalle M; Alessandrini M; Graillon T; Paladino NC; Baumstarck K; Sebag F; Dufour H; Brue T; Castinetti F
    Endocrine; 2018 Sep; 61(3):518-525. PubMed ID: 30019306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using subscales when scoring the Cushing's quality of life questionnaire.
    Tiemensma J; Depaoli S; Felt JM
    Eur J Endocrinol; 2016 Jan; 174(1):33-40. PubMed ID: 26431845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired quality of life, but not cognition, is linked to a history of chronic hypercortisolism in patients with Cushing's disease in remission.
    Pupier E; Santos A; Etchamendy N; Lavielle A; Ferriere A; Marighetto A; Resmini E; Cota D; Webb SM; Tabarin A
    Front Endocrinol (Lausanne); 2022; 13():934347. PubMed ID: 36004342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of quality of life in 102 patients with treated Cushing's disease.
    Carluccio A; Sundaram NK; Chablani S; Amrock LG; Lambert JK; Post KD; Geer EB
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):404-11. PubMed ID: 24931777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
    Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome.
    Barahona MJ; Sucunza N; Resmini E; Fernández-Real JM; Ricart W; Moreno-Navarrete JM; Puig T; Wägner AM; Rodriguez-Espinosa J; Farrerons J; Webb SM
    J Bone Miner Res; 2009 Nov; 24(11):1841-6. PubMed ID: 19453254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission.
    Ragnarsson O; Berglund P; Eder DN; Johannsson G
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1640-8. PubMed ID: 22761462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common genetic variants in the glucocorticoid receptor and the 11β-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing's syndrome in remission.
    Ragnarsson O; Glad CA; Berglund P; Bergthorsdottir R; Eder DN; Johannsson G
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1803-7. PubMed ID: 24915124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology.
    Berr CM; Di Dalmazi G; Osswald A; Ritzel K; Bidlingmaier M; Geyer LL; Treitl M; Hallfeldt K; Rachinger W; Reisch N; Blaser R; Schopohl J; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1300-8. PubMed ID: 25546155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
    Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.